# Oxaliplatin

NDC: 43066-014
Generic name: Oxaliplatin
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180219

FDA application: ANDA078817

## Active ingredients

- OXALIPLATIN: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43066-014"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43066-014
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21a2bb1d-d91d-4f99-97dd-cc67fe99a090